Starpharma (SPHRY.OB), on Thursday, announced that it has licensed the sales and marketing rights of VivaGel BV in the United States to ITF Pharma, a subsidiary of Italfarmaco S.p.A, a privately held European specialty pharmaceutical company.
from RTT - Biotech https://ift.tt/2V0TbQG
via IFTTT
No comments:
Post a Comment